Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021

Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021

The aim of this review is to update the current status of allogeneic hemopoietic stem cell transplants (HSCT) for patients with myelofibrosis (MF). We have first summarized the issue of an indication for allogeneic HSCT, discussing several prognostic scoring systems, developed to predict the outcome...

Full description

Bibliographic Details
Main Authors: Andrea Bacigalupo, Idanna Innocenti, Elena Rossi, Federica Sora, Eugenio Galli, Francesco Autore, Elisabetta Metafuni, Patrizia Chiusolo, Sabrina Giammarco, Luca Laurenti, Giulia Benintende, Simona Sica, Valerio De Stefano
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Immunology
Subjects:
myelofibrosis
allogeneic transplantation
busulfan
thiotepa
fludarabine chimerism
splenectomy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.637512/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.637512/full

Similar Items